The Evolving Role of the Outsourcing Manufacturer - Why CDMO is the new normal

[Available On-Demand]
Search General Info
How far has the biopharma industry actually embraced the technologies and methodologies of manufacturing 4.0?

Chair: Dan Stanton, BioProcess Insider
Panelist: Magnus Schroeder, Ph.D, VP Process Development, Avid Bioservices
Panelist: Daniel Slone, VP & Head of Downstream Manufacturing, Samsung Biologics
Moderator
photo
Editor
BioProcess Insider
Speaker
photo
Editor
BioProcess Insider